Multi-Omics Approaches Decipher the Immune Regulatory Network in Atherosclerotic Ischemic Stroke
CHI Cheng1, HUA Shi2, CHE Fengyuan3
1 Department of Emergency Medicine, Peking University People’s Hospital, Beijing 100044, China
2 Department of Brain Tumors and Functional Neurosurgery, Linyi People’s Hospital, Linyi 276000, China
3 Department of Neurology, Linyi People’s Hospital, Linyi 276000, China
CHI Cheng, HUA Shi, CHE Fengyuan. Multi-Omics Approaches Decipher the Immune Regulatory Network in Atherosclerotic Ischemic Stroke[J]. Chinese Journal of Stroke, 2025, 20(10): 1247-1260.
[1]STRONG K,MATHERS C,BONITA R. Preventing stroke:saving lives around the world[J]. Lancet Neurol,2007,6(2):182-187.
[2] LIAN Z Q,GAO Y K,XIONG J L,et al. Temporal trend and attributable risk factors of ischemic stroke burden in China,1990-2021[J/OL]. BMC Neurol,2025,25(1):245[2025-07-12]. https://doi.org/10.1186/s12883-025-04256-8.
[3] CUI H K,TANG C J,GAO Y,et al. An integrative analysis of single-cell and bulk transcriptome and bidirectional Mendelian randomization analysis identified C1Q as a novel stimulated risk gene for atherosclerosis[J/OL]. Front Immunol,2023,14:1289223[2025-07-12]. https://doi.org/10.3389/fimmu.2023.1289223.
[4] BURGESS S,DAVEY SMITH G,DAVIES N M,et al. Guidelines for performing Mendelian randomization investigations:update for summer 2023[J/OL]. Wellcome Open Res,2019,4:186[2025-07-12].
https://doi.org/10.12688/wellcomeopenres.15555.3.
[5] QURESHI A I,CAPLAN L R. Intracranial atherosclerosis[J]. Lancet,2014,383(9921):984-998.
[6] 中华医学会老年医学分会老年神经病学组,北京神经科学学会血管神经病学专业委员会,动脉粥样硬化性缺血性卒中/短暂性脑缺血发作合并冠心病诊治中国专家共识编写组. 动脉粥样硬化性缺血性卒中/短暂性脑缺血发作合并冠心病诊治中国专家共识(2022)[J]. 中华医学杂志,2022,102(45):3569-3580.
Geriatric Neurology Group,Geriatric Branch of Chinese Medical Association;Cerebrovascular Neurology Professional Committee,Beijing Neuroscience Society;Writing Group for Chinese Expert Consensus on Diagnosis and Treatment of Atherosclerotic Ischemic Stroke/Transient Ischemic Attack Complicated with Coronary Heart Disease. Chinese expert consensus on diagnosis and treatment of atherosclerotic ischemic stroke/transient ischemic attack complicated with coronary heart disease(2022)[J]. Natl Med J China,2022,102(45):3569-3580.
[7] ELLIS K L,ZHOU Y,BESHANSKY J R,et al. Genetic modifiers of response to glucose-insulin-potassium(GIK)infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial[J]. Pharmacogenomics J,2015,15(6):488-495.
[8] RICHARD P,FENG S,TSAI Y L,et al. SETX(senataxin),the helicase mutated in AOA2 and ALS4,functions in autophagy regulation[J]. Autophagy,2021,17(8):1889-1906.
[9] NANETTI L,CAVALIERI S,PENSATO V,et al. SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein[J/OL]. Orphanet J Rare Dis,2013,8:123[2025-07-12]. https://doi.org/10.1186/1750-1172-8-123.
[10] PFEFFER G,LEE G,PONTIFEX C S,et al. Multisystem proteinopathy due to VCP mutations:a review of clinical heterogeneity and genetic diagnosis[J/OL]. Genes(Basel),2022,13(6):1006[2025-07-12].
https://doi.org/10.3390/genes13060963.
[11] ZHENG H,HUANG S L,WEI G Q,et al. CircRNA Samd4 induces cardiac repair after myocardial infarction by blocking mitochondria-derived ROS output[J]. Mol Ther,2022,30(11):3477-3498.
[12] HATA M,IKEDA H O,KIKKAWA C,et al. KUS121,a VCP modulator,attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress[J/OL]. Sci Rep,2017,7:44873[2025-07-12]. https://doi.org/10.1038/srep44873.
[13] LAHIRI S K,LU J,AGUILAR-SANCHEZ Y,et al. Targeting calpain-2-mediated junctophilin-2 cleavage delays heart failure progression following myocardial infarction[J/OL]. J Mol Cell Cardiol,2024,194:85-95[2025-07-12]. https://doi.org/10.1016/j.yjmcc.2024.06.011.
[14] MARVIN J,RHOADS J P,MAJOR A S. FcγRⅡb on CD11c+ cells modulates serum cholesterol and triglyceride levels and differentially affects atherosclerosis in male and female Ldlr-/- mice[J/OL]. Atherosclerosis,2019,285:108-119[2025-07-12]. https://doi.org/10.1016/j.atherosclerosis.2019.04.221.
[15] LIU Y B,LAI S H,LIANG L J,et al. Study on the interaction mechanism between C-reactive protein and platelets in the development of acute myocardial infarction[J/OL]. Ann Transl Med,2021,9(12):1012[2025-07-12]. https://doi.org/10.21037/atm-21-2733.
[16] MOTA M,PORRINI V,PARRELLA E,et al. Neuroprotective epi-drugs quench the inflammatory response and microglial/macrophage activation in a mouse model of permanent brain ischemia[J/OL]. J Neuroinflammation,2020,17(1):361[2025-07-12]. https://doi.org/10.1186/s12974-020-02028-4.
[17] RAMACHANDRA N,GUPTA M,SCHWARTZ L,et al. Role of IL8 in myeloid malignancies[J]. Leuk Lymphoma,2023,64(11):1742-1751.
[18] VELASQUEZ I M,FRUMENTO P,JOHANSSON K,et al. Association of interleukin 8 with myocardial infarction:results from the Stockholm heart epidemiology program[J]. Int J Cardiol,2014,172(1):173-178.
[19] GAO M,CAI Q,BIAN Y H,et al. Protective effect of esculentoside A against myocardial infarction via targeting C-X-C motif chemokine receptor 2[J/OL]. Biomed Pharmacother,2024,174:116529[2025-07-12]. https://doi.org/10.1186/1750-1172-8-123.
[20] JASKULA K,SACHARCZUK M,GACIONG Z,et al. Cardiovascular effects mediated by HMMR and CD44
[J/OL]. Mediators Inflamm,2021:4977209[2025-07-12]. https://doi.org/10.1155/2021/4977209.
[21] SAWADA R,NAKANO-DOI A,MATSUYAMA T,et al. CD44 expression in stem cells and niche microglia/macrophages following ischemic stroke[J/OL]. Stem Cell Investig,2020,7:4[2025-07-12]. https://doi.org/10.21037/sci.2020.02.02.
[22] ALMEIDA M R,SILVA A R,ELIAS I,et al. SQSTM1 gene as a potential genetic modifier of CADASIL phenotype[J]. J Neurol,2021,268(4):1453-1460.
[23] TANG D L,KANG R. SQSTM1 is a therapeutic target for infection and sterile inflammation[J/OL]. Cytokine,2023,169:156317[2025-07-12]. https://doi.org/10.1016/j.cyto.2023.156317.
[24] MOHAMUD YUSUF A,HAGEMANN N,LUDEWIG P,et al. Roles of polymorphonuclear neutrophils in ischemic brain injury and post-ischemic brain remodeling[J/OL]. Front Immunol,2021,12:825572[2025-07-12]. https://doi.org/10.3389/fimmu.2021.825572.
[25] BREEDVELD A,GROOT KORMELINK T,VAN EGMOND M,et al. Granulocytes as modulators of dendritic cell function[J]. J Leukoc Biol,2017,102(4):1003-1016.
[26]STARK K,MASSBERG S. Interplay between inflammation and thrombosis in cardiovascular pathology[J]. Nat Rev Cardiol,2021,18(9):666-682.